期刊文献+

郁可欣胶囊质量控制研究 被引量:1

Study on quality standard of Yukexin capsules
下载PDF
导出
摘要 目的:建立郁可欣胶囊质量标准。方法:采用薄层色谱法和紫外分光光度法对郁可欣胶囊内容物进行鉴别。含量测定采用反相高效液相色谱法(RP-HPLC),用Zorbax ODS C18色谱柱(250min×4.6mm,5μm)。以甲醇-5%磷酸-三乙胺(45:55:0.35,V/V)为流动相,检测波长:360nm,流速:1mL·min^-1。结果:郁可欣胶囊内容物薄层色谱、紫外光谱与对照品金丝桃苷基本一致。金丝桃苷的保留时间为4.9min,且与其他峰的分离度大于1.5,金丝桃苷的线性范围为0.005-0.0625g·L^-1(r=0.9999),最低检测限为2.0ng,最低定量限为7.5ng,平均回收率和RSD分别为98.91%和1.62%。结论:该方法简便快速,结果准确可靠,可为郁可欣胶囊的质量评价提供有效手段。 OBJECTIVE To establish a quality standard for Yukexin Capsules. METIIOI)S Thin layer chromatography (TLC) and ultraviolet spectrophotometry(UV) were used for the identification of the content of the capsules, hyperoside in the capsules was determined using. RP-HPLC was used for the determination of hyperoside. The chromatographic procedure was carried out using Zorbax ODS C18 (250 mm × 4. 6 mm, 5μm) as an analytical column and a mixture of 45 volume of methanol, 55 volume of 5% phosphoric acid, 0. 35 volume of triethylamine as a mobile phase at a flow rate of 1. 0 mL·min^-1. The detec lion wave length was set at 360 nm. RESULTS TLC chromatogram and UV spectrum of Yukexin capsule content were same as the hyperoside standard sample. The tR of hyperoside was about 4. 9 minutes. Resolution between hyperoside and other peaks was more than 1.5 and its linear range was between 0. 005 and 0. 062 5 g·L^-1 (r= 0. 999 9). The detection limit was 2. 0 ng and the quontitation limit was 7. 5 ng. The average recovery and RSD value of hyperoside were 98.91% and 1.62%, respectively. CONCLUSION This method is sensitive and can be used for the quality control of Yukexin capsules.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2006年第5期524-526,共3页 Chinese Journal of Hospital Pharmacy
基金 全军"十五"期间面上课题(编号:01MB049)
关键词 郁可欣胶囊 金丝桃苷 薄层色谱 紫外分光光度法 高效液相色谱法 Yukexin capsule Hyperoside TLC UV HPLC
  • 相关文献

参考文献5

  • 1中国药典.一部[S].北京:化工出版社,2005.附录ⅥB.31
  • 2聂伟,张永祥,周金黄.金丝桃提取物抗抑郁作用研究与展望[J].中国实验方剂学杂志,2001,7(1):59-61. 被引量:73
  • 3Bibe A,Fischer H,Romer A,et al.Oral bioavailability of hyperforin form hypericum extracts in rats and human volunteers[J].Pharmacopsychiatry,1998,(suppl):36-43.
  • 4Calapai G,Crupi A,Firenzuoli F,et al.Effects of hypericum perforatum on levels of 5-hydroxytryptamine,noradrenaline and dopamine in the cortex,diencephalon and brainstem of the rat[H].J Pharm Pharmacol,1999,51 (6):723-727.
  • 5梁巧丽,高宏成.金丝桃素的研究进展[J].中草药,1999,30(9):705-708. 被引量:65

二级参考文献21

  • 1中国药科大学.中药辞海(第2卷)[M].北京:中国医药科技出版社,1996.380.
  • 2[2]Linde K,Mulrow CD. St. John's wort for depression[J].Cochrane Database Syst Rev, 2000,2:CD000448.
  • 3[3]Woelk H, Burkard G, Grunwald J. Benefits and risks of the Hypericum extract LI160:drug rnonitoring study with 3250 patients. J. Geriatr[J]. Psychiatry Neurol, 1994,7(suppl 1 ) :S3~S8.
  • 4[4]Wheatley D. LI160,an extract of St. John's wort, versus amitriptyline in mildly to moderately depressed outpatients-a controlled 6-week clinical trial[J]. Pharmacopsychiat, 1997,30(suppl) :77~80.
  • 5[5]Miiller W E,Rolli M, Schafer C, et al. Effects of hypericum extract (LI160) in biochemical models of antidepressant activity[J ]. Pharmacopsychiat, 1997, 30 (suppl):102~107.
  • 6[6]Yu PH. Effect of the hypericum perforatum extract on serotonin turnover in the mouse brain[J]. Pharmacopsychiatry, 2000,33(2) :60~5.
  • 7[7]Linde K, Ramirez G, Mulrow CD,et al. St. John's wort for depression-an overview and metaanalysis of randomized clinical trials[J]. BMJ, 1996,313:253~258.
  • 8[8]Perovic S, Miiller WEG. Pharmacological profile of hypericum extract. Effect on serotomn uptake by receptors[J]. Arzneim. Forsch, 1995,45:1145 ~ 1148.
  • 9[9]Thiele B, Brink I, Ploch M. Modulation of cytokine expression of serotonin receptors. J. Geriatr [ J ]. Psychiatry. Neurol, 1994,7(suppl):S63~64.
  • 10[10]Winterhof H, Butterweck V, Nahrstedt A, et al. Phytopharmaka in Forschung unf klinischer Anwendung,Darmstadt, Germany: Steinkopff Verlag GmbH and Co.KG, 1995,s39~ 52.

共引文献154

同被引文献33

引证文献1

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部